UK-based analysis expertise firm uMed has raised £3.7 million to assist healthcare suppliers within the UK and US, together with GPs, hospitals and well being specialists, run affected person analysis extra effectively whereas safeguarding affected person knowledge and making certain regulatory compliance.
VC buyers AlbionVC, Delin Ventures and Playfair Capital are backing uMed’s newest spherical of funding, together with Silicon Valley’s 11.2 Capital to bolster the corporate’s US presence.
uMed’s platform automates the scientific research course of, creating regulatory high quality affected person registries that mix digital well being knowledge with structured knowledge captured from every affected person.
WHY IT MATTERS
Medical analysis research can price many tens of millions of kilos every, and as much as 80% of those prices are related to handbook processes delegated to healthcare suppliers which uMed goals to eradicate.
uMed is delivering its expertise to numerous scientific analysis research together with the College of Oxford-led RAPTOR-C19 research, a part of the nationwide precedence CONDOR platform evaluating using COVID-19 diagnostics in several settings.
RAPTOR-C19 is evaluating the accuracy of various speedy checks for COVID-19 amongst sufferers in group settings, akin to GP surgical procedures. These findings are informing the scaling up of testing within the UK, which is a key precedence in serving to scientists higher perceive and management COVID-19 transmission.
The uMed platform gives the performance required to digitally goal and have interaction sufferers for this research, enabling e-consent and the automated seize of structured outcomes remotely that are linked again to the information from every affected person file.
This ensures the environment friendly execution of the research throughout numerous websites, and creates the capability for healthcare suppliers to take part in lots of extra of those research than would in any other case be attainable.
THE LARGER CONTEXT
In associated information, well being tech firm 54gene recently launched a clinical research programme in Nigeria to supply end-to-end scientific improvement providers.
ON THE RECORD
uMed’s founder and CEO, Dr Matt Wilson mentioned: “Our expertise can help healthcare suppliers find applicable sufferers to take part in medical analysis together with massive scale affected person registries which often calls for laborious, handbook processes on high of their already advanced and heavy workloads.
“As our expertise is uniquely in a position to attain again compliantly from the Digital Well being Report (EHR) to the sufferers, the method for constructing analysis registries will be closely automated. It means clinicians can deal with affected person care, whereas sufferers are given the chance to take part in lots of extra research from residence with full transparency over use of their well being information.”